Clinical Trial Update: Effects of Cladribine Tablets on the PK of Microgynon® [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating effects of cladribine tablets on the pharmacokinetics of Microgynon® in relapsing multiple sclerosis patients has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)
• Microgynon (ethinylestradiol/levonorgestrel)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Relapsing Multiple Sclerosis (RMS) | Phase 1 | Status: COMPLETED | Results posted: 2024-03-15